IBDEI207 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33995,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,33996,0)
 ;;=D75.1^^131^1680^180
 ;;^UTILITY(U,$J,358.3,33996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33996,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,33996,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,33996,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,33997,0)
 ;;=C90.30^^131^1680^183
 ;;^UTILITY(U,$J,358.3,33997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33997,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,33997,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,33997,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,33998,0)
 ;;=D56.3^^131^1680^184
 ;;^UTILITY(U,$J,358.3,33998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33998,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,33998,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,33998,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,33999,0)
 ;;=D56.9^^131^1680^185
 ;;^UTILITY(U,$J,358.3,33999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33999,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,33999,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,33999,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,34000,0)
 ;;=M31.1^^131^1680^187
 ;;^UTILITY(U,$J,358.3,34000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34000,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,34000,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,34000,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,34001,0)
 ;;=D51.2^^131^1680^188
 ;;^UTILITY(U,$J,358.3,34001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34001,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,34001,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,34001,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,34002,0)
 ;;=D05.92^^131^1680^35
 ;;^UTILITY(U,$J,358.3,34002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34002,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,34002,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,34002,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,34003,0)
 ;;=D05.91^^131^1680^37
 ;;^UTILITY(U,$J,358.3,34003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34003,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,34003,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,34003,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,34004,0)
 ;;=D05.90^^131^1680^33
 ;;^UTILITY(U,$J,358.3,34004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34004,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,34004,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,34004,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,34005,0)
 ;;=D51.0^^131^1680^189
 ;;^UTILITY(U,$J,358.3,34005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34005,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,34005,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,34005,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,34006,0)
 ;;=D51.1^^131^1680^190
 ;;^UTILITY(U,$J,358.3,34006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34006,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,34006,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,34006,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,34007,0)
 ;;=D51.9^^131^1680^192
 ;;^UTILITY(U,$J,358.3,34007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34007,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,34007,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,34007,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,34008,0)
 ;;=D68.0^^131^1680^194
 ;;^UTILITY(U,$J,358.3,34008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34008,1,3,0)
 ;;=3^Von Willebrand's Disease
